CN Patent

CN115175738A — 经历分子内重排的结合物

Assigned to Ascendis Pharma AS · Expires 2022-10-11 · 4y expired

What this patent protects

本发明涉及结合物及其可药用盐、试剂、中间体、合成所述结合物的方法、包含所述结合物的药物组合物以及所述结合物的用途。

USPTO Abstract

本发明涉及结合物及其可药用盐、试剂、中间体、合成所述结合物的方法、包含所述结合物的药物组合物以及所述结合物的用途。

Drugs covered by this patent

Yorvipath (PALOPEGTERIPARATIDE) · Ascendis Pharma Bone

Patent Metadata

Patent number: CN115175738A
Jurisdiction: CN
Classification: —
Expires: 2022-10-11
Drug substance claim: No
Drug product claim: No
Assignee: Ascendis Pharma AS
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.